Three landmark studies highlight expanded benefits of kidney drug finerenone
June 05, 2026
June 05, 2026
NEWTON, New South Wales, June 5 [Category: Health Care] -- The George Institute for Global Health issued the following news release:
* * *
Three landmark studies highlight expanded benefits of kidney drug finerenone
*
A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival across a much broader range of patients with chronic kidney disease (CKD) than it is currently recom . . .
* * *
Three landmark studies highlight expanded benefits of kidney drug finerenone
*
A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival across a much broader range of patients with chronic kidney disease (CKD) than it is currently recom . . .